Table 1 Clinicopathological characteristics of patient with cervical sarcoma (n = 34)
From: Sarcoma of the uterine cervix: experience of a single center
Clinical Characteristics | n | % |
|---|---|---|
Age (years) | ||
<40 | 16 | 47.1 |
≥40 | 18 | 52.9 |
Primary symptoms | ||
Vaginal bleeding | 24 | 70.6 |
Physical examination | 7 | 20.6 |
Vaginal introital mass | 2 | 5.9 |
Vaginal drainage | 1 | 2.9 |
Tumor size (cm) | ||
<5 | 14 | 41.2 |
≥5, <10 | 13 | 38.2 |
≥10 | 7 | 20.6 |
Pathologic Stage (FIGO 2018) | ||
I | 21 | 61.8 |
II | 4 | 11.8 |
III | 6 | 17.6 |
IV | 3 | 8.8 |
Pathological subtype | ||
leiomyosarcoma | 7 | 20.6 |
carcinosarcoma | 6 | 17.6 |
Ewing’s sarcoma | 5 | 14.7 |
rhabdomyosarcoma | 4 | 11.8 |
undifferentiated sarcoma | 4 | 11.8 |
sarcoma not otherwise specified | 2 | 5.9 |
adenosarcoma | 2 | 5.9 |
endometrial stromal sarcoma | 2 | 5.9 |
alveolar soft tissue sarcoma | 1 | 2.9 |
dermatofibrosarcoma protuberans | 1 | 2.9 |
Surgical treatment | ||
Yes | 30 | 88.2 |
No | 4 | 11.8 |
Neoadjuvant chemotherapy | ||
Yes | 7 | 20.6 |
No | 27 | 79.4 |
Surgery type | ||
Radical hysterectomy | 14 | 46.7 |
Hysterectomy | 15 | 50.0 |
Tumor resection | 1 | 3.3 |
No surgery | 4 | |
Cervical stromal invasion | ||
Inner 1/3 | 8 | 28.6 |
Middle 1/3 | 3 | 10.7 |
Outer 1/3 | 17 | 60.7 |
NA | 6 | |
Lymphvascular space invasion | ||
Positive | 18 | 62.1 |
Negative | 11 | 37.9 |
NA | 5 | |
Pelvic lymph node | ||
Positive | 3 | 21.4 |
Negative | 11 | 78.6 |
NA | 20 | |
Para-aortic lymph node | ||
Positive | 1 | 16.7 |
Negative | 5 | 83.3 |
NA | 28 | |
Adjuvant chemotherapy | ||
Yes | 21 | 70.0 |
No | 9 | 30.0 |
NA | 4 | |
Adjuvant radiotherapy | ||
Yes | 4 | 13.3 |
No | 26 | 86.7 |
NA | 4 | |